Back close
Publications
Critical evaluation of the utility of pre- and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALL

Citation : Das N, Gupta R, Gupta SK, Bakhshi S, Seth R, Kumar C, Rai S, Singh S, Prajapati VK, Gogia A, Sahoo R ...

Publisher :Ann Hematol

Publications
Does technology make start-ups resilient amidst COVID-19? A qualitative enquiry

Citation : Tiwari, A., Das, P., Dubey, R.K., Kaur, T., Dixit, S.K. and Mandal, S. (2023), "Does technology make ...

Publisher :Scopus Indexed

Publications
A Realworld Perspective of CD123 Expression in Acute Leukemia as Promising Biomarker to Predict Treatment Outcome in B-ALL and AML

Citation : Das N, Gupta R, Gupta SK, Bakhshi S, Malhotra A, Rai S, Singh S, Prajapati VK, Sahoo RK, Gogia A, Sh ...

Publisher :Clin Lymphoma Myeloma Leuk

Publications
Cell-free DNA for genomic profiling and minimal residual disease monitoring in Myeloma- are we there yet?

Citation : Thakral D*, Das N*, Basnal A, Gupta R. Cell-free DNA for genomic profiling and minimal residual dise ...

Publisher :Am J Blood Res

Publications
Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous? -A retrospective cohort study

Citation : Sirohiya P, Elavarasi A, Sagiraju HKR, Baruah M, Gupta N, Garg RK, Paul SS, Ratre BK, Singh R, Kumar ...

Publisher :Lung India

Publications
Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with patternbased recognition

Citation : Das N, Dahiya M, Gupta R, Rai S, Singh S, Prajapati VK, Kumar L, Sharma A, Sahoo RK, Gogia A. Flow c ...

Publisher :Cytometry B Clin Cytom

Publications
Effect of the sequence of pull of bone marrow aspirates on plasma cell quantification in plasma cell proliferative disorders

Citation : Jain G, Das N, Gajendra S, et al. Effect of the sequence of pull of bone marrow aspirates on plasma ...

Publisher :Int J Lab Hematol

Publications
Genomic landscape of mature B-cell non-Hodgkin lymphomas – An appraisal from lymphomagenesis to drug resistance

Citation : Panda D, Das N, Thakral D, Gupta R. Genomic landscape of mature B-cell non-Hodgkin lymphomas - An ap ...

Publisher :Journal of the Egyptian National Cancer Institute

Publications
Relevance of polyclonal plasma cells and post-therapy immunomodulation in measurable residual disease assessment in multiple myeloma

Citation : Das N, Dahiya M, Gupta R, Kumar L, Sharma A, Rai S, Singh S, Prajapati VK, Sahoo RK, Gogia A. Releva ...

Publisher :Cytometry B Clin Cytom

Publications
Utility of CD229 as novel marker in measurable residual disease assessment in Multiple Myeloma – an evidence-based approach

Citation : Rai S*, Das N*, Gupta R, Kumar L, Sharma A, Singh S, Prajapati VK. Utility of CD229 as novel marker ...

Publisher :Int J Lab Hematol

Publications
Voyage of Measurable Residual Disease (MRD) Assessment in Multiple Myeloma Using Multiparametric Flow Cytometry

Citation : Das N & Gupta R. (2023). Voyage of Measurable Residual Disease (MRD) Assessment in Multiple Myeloma ...

Publisher :Indian Journal of Medical and Paediatric Oncology

Publications
Graded Depth of Response and Neoplastic Plasma Cell Index as Indicators of Survival Outcomes in Patients With Multiple Myeloma Following Autologous Stem Cell Transplant

Citation : Das N, Dahiya M, Gupta R, Kumar L, Rani L, Gupta A, Farswan A, Sharma A, Sharma OD. Graded Depth of ...

Publisher :Am J Clin Pathol.

Admissions Apply Now